Maurice Ferre

Solo Angel AI focus Miami, FL, United States

About Maurice Ferre

Maurice Ferre is the executive chairman of INSIGHTEC and a long-tenured medical device entrepreneur (formerly Mako Surgical), based in Miami with $100k-$250k checks at seed and Series A in medical devices and digital health. His operating credentials in surgical robotics and focused ultrasound make him one of the more credentialed device-and-procedure angels in the US market. Founders building surgical robotics, image-guided therapy, AI-enabled devices, or device-software hybrids where his INSIGHTEC and Mako pattern recognition adds meaningful operating signal are the natural fit. The AI focus flag pairs naturally with the current wave of AI-enabled imaging and procedural guidance companies. He is the wrong audience for software-only digital health, biotech, or anything outside the device-and-procedure stack. The check size is meaningful for an early device round but not large enough to lead institutional Series A. Outreach via LinkedIn is the primary channel, with warm introductions through the device community (Stanford Biodesign alumni, Mako and INSIGHTEC alumni, or focused ultrasound clinical networks) materially outperforming cold notes. Diligence will be sharply technical and clinical-evidence focused, so come with a clear regulatory pathway, clinical strategy, and reimbursement thinking rather than vision-first storytelling. This is a high-quality angel for a narrow but well-defined set of device founders.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.
Portfolio data coming soon. Know their portfolio? Suggest an edit →
Team information coming soon. Know the partners? Suggest an edit →

Pitch / review this investor

Have you raised from Maurice Ferre? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.